These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9248702

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes.
    Cara JF, Nakagawa SH, Tager HS.
    Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179
    [Abstract] [Full Text] [Related]

  • 3. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
    Leyer S, Gattner HG, Leithäuser M, Brandenburg D, Wollmer A, Höcker H.
    Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Selective response to insulin versus insulin-like growth factor-I and -II and up-regulation of insulin receptor splice variant B in the differentiated mouse mammary epithelium.
    Berlato C, Doppler W.
    Endocrinology; 2009 Jun; 150(6):2924-33. PubMed ID: 19246539
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Structural analogs of human insulin-like growth factor I with reduced affinity for serum binding proteins and the type 2 insulin-like growth factor receptor.
    Bayne ML, Applebaum J, Chicchi GG, Hayes NS, Green BG, Cascieri MA.
    J Biol Chem; 1988 May 05; 263(13):6233-9. PubMed ID: 2966152
    [Abstract] [Full Text] [Related]

  • 11. Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells.
    Bähr M, Kolter T, Seipke G, Eckel J.
    Eur J Pharmacol; 1997 Feb 12; 320(2-3):259-65. PubMed ID: 9059862
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule.
    Oh Y, Beukers MW, Pham HM, Smanik PA, Smith MC, Rosenfeld RG.
    Biochem J; 1991 Aug 15; 278 ( Pt 1)(Pt 1):249-54. PubMed ID: 1715685
    [Abstract] [Full Text] [Related]

  • 16. Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications.
    Zhao M, Wan ZL, Whittaker L, Xu B, Phillips NB, Katsoyannis PG, Ismail-Beigi F, Whittaker J, Weiss MA.
    J Biol Chem; 2009 Nov 13; 284(46):32178-87. PubMed ID: 19773552
    [Abstract] [Full Text] [Related]

  • 17. Systematic evaluation of the metabolic to mitogenic potency ratio for B10-substituted insulin analogues.
    Glendorf T, Knudsen L, Stidsen CE, Hansen BF, Hegelund AC, Sørensen AR, Nishimura E, Kjeldsen T.
    PLoS One; 2012 Nov 13; 7(2):e29198. PubMed ID: 22383948
    [Abstract] [Full Text] [Related]

  • 18. N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions.
    Hashimoto R, Fujiwara H, Higashihashi N, Enjoh-Kimura T, Terasawa H, Fujita-Yamaguchi Y, Inagaki F, Perdue JF, Sakano K.
    J Biol Chem; 1995 Jul 28; 270(30):18013-8. PubMed ID: 7629109
    [Abstract] [Full Text] [Related]

  • 19. ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor.
    Milazzo G, Sciacca L, Papa V, Goldfine ID, Vigneri R.
    Mol Carcinog; 1997 Jan 28; 18(1):19-25. PubMed ID: 9022809
    [Abstract] [Full Text] [Related]

  • 20. Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir.
    Varewijck AJ, Goudzwaard JA, Brugts MP, Lamberts SW, Hofland LJ, Janssen JA.
    Growth Horm IGF Res; 2010 Dec 28; 20(6):427-31. PubMed ID: 21055982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.